| abstract |
The present application relates to a novel heterocyclic substituted 6-(trifluoromethyl)pyrimidin-4(3H)-one derivative, a process for the preparation thereof, and the use thereof, alone or in combination, for the treatment and/or prevention of diseases, And its use in the manufacture of a medicament for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prevention of cardiovascular, renal, inflammatory and fibrotic diseases. |